According to Biolase 's latest financial reports and stock price the company's current Operating Margin is -41.06%. At the end of 2021 the company had an Operating Margin of -41.07%.
Year | Operating Margin | Change |
---|---|---|
2021 | -41.07% | -43.99% |
2020 | -73.31% | 54.82% |
2019 | -47.35% | 1.88% |
2018 | -46.48% | 25.12% |
2017 | -37.15% | 26.46% |
2016 | -29.38% | -29.15% |
2015 | -41.46% | 5.03% |
2014 | -39.48% | 91.29% |
2013 | -20.64% | 301.94% |
2012 | -5.13% | -42.95% |
2011 | -9.00% | -80.27% |
2010 | -45.62% | 596.99% |
2009 | -6.54% | -53.05% |
2008 | -13.94% | 31% |
2007 | -10.64% | 63.82% |
2006 | -6.49% | -76.65% |
2005 | -27.82% | 91.7% |
2004 | -14.51% | -192.89% |
2003 | 15.62% | 83.85% |
2002 | 8.50% | -517.54% |
2001 | -2.03% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | 16.04% | -139.06% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | -26.89% | -34.51% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.